The UPS: a promising target for breast cancer treatment
2008
The UPS: a promising target for breast cancer treatment
publication
Evidence: moderate
Author Information
Author(s): Sato Ko, Rajendra Eeson, Ohta Tomohiko
Primary Institution: St Marianna University School of Medicine
Hypothesis
Can small molecules targeting the ubiquitin proteasome system improve breast cancer treatment outcomes?
Conclusion
Targeting the ubiquitin proteasome system may provide new therapeutic options for breast cancer, especially for aggressive subtypes.
Supporting Evidence
- Progress in hormone therapy has improved breast cancer prognosis.
- Small molecules targeting the ubiquitin proteasome system are being explored for breast cancer treatment.
- Bortezomib has shown efficacy in multiple myeloma, suggesting potential for other cancers.
Takeaway
Scientists are looking at a system in our cells that helps break down proteins to find new ways to treat breast cancer.
Methodology
This review summarizes the ubiquitin proteasome pathways related to breast cancer and discusses potential new drugs.
Limitations
The review does not provide experimental data or clinical trial results specific to breast cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website